BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27372382)

  • 1. Cylindromatosis (Cyld) gene mutation in T cells promotes the development of an IL-9-dependent allergic phenotype in experimental asthma.
    Reuter S; Maxeiner J; Meyer-Martin H; Michel A; Baars P; Bopp T; Waisman A; Reissig S; Wehler TC; Schild H; Taube C; Stassen M; Becker M
    Cell Immunol; 2016 Oct; 308():27-34. PubMed ID: 27372382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated cylindromatosis gene affects the functional state of dendritic cells.
    Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
    Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
    Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
    Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor CYLD controls the function of murine regulatory T cells.
    Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
    J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.
    Srokowski CC; Masri J; Hövelmeyer N; Krembel AK; Tertilt C; Strand D; Mahnke K; Massoumi R; Waisman A; Schild H
    Blood; 2009 Jun; 113(23):5891-5. PubMed ID: 19342479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.
    Hunstig F; Schulz S; Nieten I; Froster U; Boltze C; Schliemann S; Hochhaus A; La Rosée P
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):845-8. PubMed ID: 26660106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome.
    Nagy N; Farkas K; Kinyo A; Nemeth IB; Kis E; Varga J; Bata-Csorgo Z; Kemeny L; Szell M
    Exp Dermatol; 2012 Dec; 21(12):967-9. PubMed ID: 23171463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF3 and NBR1 both influence the effect of the disease-causing CYLD(Arg936X) mutation on NF-κB activity.
    Danis J; Kelemen E; Rajan N; Nagy N; Széll M; Ádám É
    Exp Dermatol; 2021 Nov; 30(11):1705-1710. PubMed ID: 33999445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.
    van den Ouweland AM; Elfferich P; Lamping R; van de Graaf R; van Veghel-Plandsoen MM; Franken SM; Houweling AC
    Fam Cancer; 2011 Mar; 10(1):127-32. PubMed ID: 20972631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.
    Cranston A; Stocken DD; Stamp E; Roblin D; Hamlin J; Langtry J; Plummer R; Ashworth A; Burn J; Rajan N
    Trials; 2017 Mar; 18(1):111. PubMed ID: 28270164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
    Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
    Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new Cylindromatosis (CYLD) gene mutation in a case of Brooke-Spiegler syndrome masquerading as basal cell carcinoma of the eyelids.
    Hester CC; Moscato EE; Kazakov DV; Vanecek T; Moretto JC; Seiff SR
    Ophthalmic Plast Reconstr Surg; 2013; 29(1):e10-1. PubMed ID: 22689134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
    Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
    Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene.
    Farkas K; Deák BK; Sánchez LC; Martínez AM; Corell JJ; Botella AM; Benito GM; López RR; Vanecek T; Kazakov DV; Kromosoeto JN; van den Ouweland AM; Varga J; Széll M; Nagy N
    BMC Genet; 2016 Feb; 17():36. PubMed ID: 26861065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
    Parren LJMT; Giehl K; van Geel M; Frank J
    Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
    Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
    Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel frameshift mutation in the cylindromatosis (CYLD) gene in a Chinese family with multiple familial trichoepithelioma.
    Wu JW; Xiao SX; Huo J; An JG; Ren JW
    Arch Dermatol Res; 2014 Nov; 306(9):857-60. PubMed ID: 25234269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.
    Alameda JP; García-García VA; López S; Hernando A; Page A; Navarro M; Moreno-Maldonado R; Paramio JM; Ramírez Á; García-Fernández RA; Casanova ML
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.